Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-13 Sale |
2023-06-15 7:25 pm |
BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner |
1,198,128 | $188.88 | $226,306,339 | 142,888,241 (Indirect) |
View |
| 2023-06-08 Sale |
2023-06-12 9:57 pm |
BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner |
2,956,689 | $201.98 | $597,183,858 | 144,086,369 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-05 Option Award |
2024-06-07 4:58 pm |
N/A 2034-06-04 |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
50,492 | $0 | 2,752,615 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:57 pm |
N/A 2034-06-04 |
BeiGene Ltd. | BGNE | Riva Alessandro Director |
50,492 | $0 | 80,106 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:56 pm |
N/A 2034-06-04 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
519,649 | $0 | 11,165,677 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:55 pm |
N/A 2034-06-04 |
BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director |
50,492 | $0 | 80,392 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:54 pm |
N/A 2034-06-04 |
BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer |
392,899 | $0 | 712,985 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:31 pm |
N/A 2034-06-04 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
50,492 | $0 | 80,106 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:03 pm |
N/A 2034-06-04 |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
169,286 | $0 | 10,852,438 (Indirect) |
View |
Ownership |
2024-03-26 5:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Ball Titus B. Principal Accounting Officer |
0 | $0 | 38,155 (Direct) |
View |
| 2024-03-11 Gift |
2024-03-13 5:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
82,020 | $0 | 2,702,123 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 5:24 pm |
N/A 2034-02-28 |
BeiGene Ltd. | BGNE | BRANDICOURT OLIVIER Director |
27,794 | $0 | 27,794 (Direct) |
View |
| 2023-11-30 Other |
2023-12-04 5:44 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
172,372 | $0 | 10,818,400 (Indirect) |
View |
| 2023-11-30 Gift |
2023-12-04 5:44 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
71,890 | $0 | 10,818,400 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 7:08 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director |
39,897 | $0 | 64,389 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 7:01 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Riva Alessandro Director |
39,897 | $0 | 56,589 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 7:00 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Malley Thomas Director |
39,897 | $0 | 103,671 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:59 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director |
39,897 | $0 | 64,389 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:58 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
39,897 | $0 | 2,811,118 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:56 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Dugan Margaret Director |
39,897 | $0 | 56,589 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:55 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel |
314,535 | $0 | 430,547 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:53 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
640,861 | $0 | 565,422 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:51 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer |
516,828 | $0 | 409,058 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:49 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
961,298 | $0 | 777,216 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:47 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
413,465 | $0 | 11,217,539 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:46 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,705,548 | $0 | 50,162,224 (Direct) |
View |
Ownership |
2023-06-20 6:37 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel |
0 | $0 | 304,941 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:34 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
133,744 | $0 | 11,891,052 (Indirect) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:30 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
39,897 | $0 | 56,589 (Direct) |
View |